CD200 and cancer: Expression of the immunosuppressive type 1 transmembrane glycoprotein, CD200, also known as OX-2 membrane glycoprotein, has been described in various types of cancer stem cells [75], including BCC, in which expression is restricted to a small population of cancer stem cells [75,76].